Neimeth International Pharmaceuticals Plc (NGX: NEIMETH)

NEIMETH Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020
Period Ending	Nov 19, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	8,461	8,290	2,716	2,659	3,324	3,513
Market Cap Growth	14.88%	205.24%	2.14%	-20.00%	-5.41%	362.50%
Enterprise Value	10,576	9,264	5,237	4,683	5,412	5,187
Last Close Price	1.98	1.94	1.43	1.40	1.68	1.72
PE Ratio	-	-	-	-	12.28	16.54
PS Ratio	2.23	3.75	0.93	0.98	1.09	1.24
PB Ratio	4.75	5.64	3.49	2.43	2.35	2.76
P/TBV Ratio	4.63	5.64	3.49	2.43	2.35	2.76
P/FCF Ratio	-	-	-	-	1693.08	-
P/OCF Ratio	18.08	-	20.49	-	9.60	11.61
EV/Sales Ratio	2.79	4.19	1.79	1.73	1.78	1.83
EV/EBITDA Ratio	24.14	-	54.54	49.41	8.47	6.41
EV/EBIT Ratio	36.42	-	-	-	9.86	7.43
EV/FCF Ratio	-28.03	-	-	-	2756.94	-
Debt / Equity Ratio	2.33	2.87	4.68	3.05	2.15	2.59
Debt / EBITDA Ratio	9.48	-	35.20	35.15	4.64	4.08
Debt / FCF Ratio	-	-	-	-	1551.72	-
Asset Turnover	0.40	0.29	-	0.43	0.48	0.62
Inventory Turnover	0.98	0.79	-	1.02	1.12	1.22
Quick Ratio	0.45	0.43	0.48	0.63	1.53	1.64
Current Ratio	0.78	0.75	1.00	1.24	2.28	2.34
Return on Equity (ROE)	-71.93%	-254.91%	-	-8.74%	20.13%	18.11%
Return on Assets (ROA)	1.92%	-6.22%	-	-0.24%	5.41%	9.53%
Return on Capital (ROIC)	2.79%	-9.51%	-	-0.35%	7.60%	13.13%
Earnings Yield	-23.43%	-34.56%	-11.97%	-4.12%	8.14%	6.05%
FCF Yield	-4.46%	-20.62%	-41.87%	-45.31%	0.06%	-7.44%
Dividend Yield	0.00%	-	-	-	4.16%	3.78%
Payout Ratio	0.00%	-	-	-	45.62%	-
Buyback Yield / Dilution	-16.13%	-125.00%	-	-	-	-
Total Shareholder Return	-16.13%	-125.00%	-	-	4.16%	3.78%

Source: S&P Capital IQ. Standard template. Financial Sources.